Personal information
Chavakis, Triantafyllos, Prof. Dr. med.
Institute for Clinical Chemistry and Laboratory Medicine
University Hospital Carl Gustav Carus
Technische Universität Dresden (TUD)
Current position
Professor of Clinical Chemistry and Clinical Pathobiochemistry
Director of the Institute for Clinical Chemistry and Laboratory Medicine (since 2017)
Role within partner site
Research on innate immunity and immunometabolism;
Relevant work experience
Immunologist with focus on trained innate immunity;
2019–2022 MPI-CBG-Fellow, MPI-CBG Dresden
2019–2022 Visiting Professor, Centre for Cardiovascular Science, Queen’s Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, UK
2018– Faculty Member, National Center for Tumor Diseases, Partner Site Dresden of the German Cancer Research Center, Heidelberg
2017– Professor & Director Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, TUD
2014–2017 Professor & Head, Department of Clinical Pathobiochemistry at the Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, TUD
2011– Faculty Member, Paul Langerhans Institute for Diabetes Research, Dresden of the Helmholtz Center Munich and German Center for Diabetes Research
2010–2014 Professor Medical Clinic I, University Hospital Carl Gustav Carus, TUD
Professional background
2001 Doctorate (Dr. med.), Justus-Liebig-Universität Giessen
1993–2000 Studies in Human Medicine, Justus-Liebig-Universität Giessen
Main research focus
Inflammatory diseases, metabolic diseases, innate immunity, immunometabolism;
Publications
5 out of 232; SCOPUS h-index 62* equally contributing authors
Kourtzelis I, …, Hajishengallis G*, Chavakis T* (2019). DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat Immunol 20:40–49.
Chavakis T*, Mitroulis I*, Hajishengallis G* (2019). Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat Immunol 20:802–811.
Mitroulis I, …, Hajishengallis G*, Netea MG*, Chavakis T* (2018). Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 72:147–161. (~200 citations)
Chung KJ, …, Chavakis T (2017). A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity. Nat Immunol 18:654–664.
Choi EY, …, Chavakis T (2008). Del-1, an endogenous leukocyte endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322:1101–1104.
Additional information
Grants: ERC-Grant (2017–2021); R. Koselleck Grant of the DFG (2011–2017); ERC-Grant (2011–2016);
Societies: European Society for Clinical Investigation Award for Excellence in Translational Research (2012)
